EPO Linked to Brain Aneurysms
Banned drug restricts blood flow
On Friday, the Swiss journal FASEB published a study that links synthetic erythropoietin, or EPO, with an increased risk of brain aneurysms. The drug is commonly used by athletes to boost performance in endurance races and is banned by the World Anti-Doping Agency. In the study, even low doses were shown to constrict arteries and decrease blood flow to the brain. "Now we know that folks who use EPO covertly are cheating not only the time-clock, but themselves,” said Gerald Weissmann, M.D., Editor-in-Chief of FASEB.
Read more at FASEB Journal
Our mission to inspire readers to get outside has never been more critical. In recent years, Outside Online has reported on groundbreaking research linking time in nature to improved mental and physical health, and we’ve kept you informed about the unprecedented threats to America’s public lands. Our rigorous coverage helps spark important debates about wellness and travel and adventure, and it provides readers an accessible gateway to new outdoor passions. Time outside is essential—and we can help you make the most of it. Making a financial contribution to Outside Online only takes a few minutes and will ensure we can continue supplying the trailblazing, informative journalism that readers like you depend on. We hope you’ll support us. Thank you.
Contribute to Outside →